|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 |
| (11) | Number of the document | 3082870 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14819058.0 |
| Date of filing the European patent application | 2014-12-19 | |
| (97) | Date of publication of the European application | 2016-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/053804 |
| Date | 2014-12-19 |
| (87) | Number | WO 2015/092435 |
| Date | 2015-06-25 |
| (30) | Number | Date | Country code |
| 201361919404 P | 2013-12-20 | US |
| (72) |
LEE, Richard, GB
ANDREW, Dick, GB
BOWERS, Lauren Schewitz, GB
NUSSENBLATT, Robert, US
GERY, Igal, US
WEI, Lai, US
|
| (73) |
The University of Bristol,
Senate House Tyndall Avenue, Bristol BS8 1TH,
GB
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human, 6011 Executive Boulevard Office of Technology Transfer National Institutes of Health Suite 325, MSC 7660, Bethesda, Maryland 20892, US |
| (54) | CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT |
| CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT |